Sporadic solid hemangioblastoma of the cerebellar vermis: A case report Authors: Abiodun Idowu Okunlola, Kasiemobi Eberechukwu Uchime, Olaniyi Abiodun Olatunde, Shina Abidemi Olalere, Kolawole Alexander Ige, Cecilia Kehinde Okunlola Published: 2026 ABSTRACT Background: Hemangioblastomas are rare, benign tumors of the central nervous system, most commonly affecting the cerebellum, brainstem, and spinal cord. They are often associated with von Hippel-Lindau disease but can also occur sporadically.Case Description: This case report presents a 60-year-old male with a sporadic solid hemangioblastoma of the cerebellar vermis, detailing his clinical presentation, radiological findings, surgical management, and postoperative outcome.Conclusion: Although rare, these tumors should be considered in the differential diagnosis of posterior fossa masses in adults. Gross total excision is curative with a good prognosis. INTRODUCTION Hemangioblastomas account for approximately 1–2% of all intracranial tumors and approximately 0.5% of all primary brain tumors.[7] They are typically found in the posterior fossa. These tumors are typically cystic in nature and less commonly solid.[7] Approximately 70% of hemangioblastomas occur sporadically, with about 30% linked to von Hippel–Lindau (VHL) disease. Among sporadic cases, presentation of the solid variant in elderly patients is rare.[6] We present a case of a 60-year-old male diagnosed with a solid cerebellar vermis hemangioblastoma, who was successfully managed. CASE PRESENTATION A 60-year-old male with no significant past medical history presented with progressive gait instability, dizziness, and intermittent headaches of 6 months’ duration. He required assistance for his daily activities such as walking, grooming, and feeding. There was no history of visual disturbances. There was no significant family history. Examination revealed a middle-aged man with normal mental status, ataxic gait, truncal ataxia, and dysmetria in the limbs. The ophthalmology and otolaryngology examinations were normal. The skin examination showed no abnormal pigmentation or lesions. The chest and abdominal examination yielded normal findings. The prostate was normal in size and consistency (digital rectal examination [DRE] unremarkable). Comprehensive examination of the other systems was normal. Radiologic investigations, including plain chest X-ray and abdominopelvic ultrasound, were normal and showed no evidence of tumor. Prostate-specific antigen (PSA) testing was not performed, given the normal DRE, absence of urinary symptoms or known prostate history, and low pretest probability of prostate metastasis in this context (brain metastases from prostate cancer are rare, comprising <1% of cases overall and <8% in the posterior fossa).[10] Brain MRI showed a well-circumscribed, intensely enhancing solid mass in the cerebellar vermis with small cystic components [Figure 1A and B]. Gross total tumor excision was achieved; the floor of the fourth ventricle was clean with egress of cerebrospinal fluid. Postoperative cranial computed tomography (CT) scan showed gross total tumor excision [Figure 1C and D]. The patient underwent a midline suboccipital craniectomy with gross total resection of the tumor under general anesthesia. The patient was positioned prone on head ring, chest, and pelvic bolsters, and an intermittent calf compression device was applied. The scalp was shaved and prepared with Savlon and 10% povidone iodine solution. Disposable sterile surgical drapes were used to isolate the operating site. The midline was marked and infiltrated with 30 mL of 1% lidocaine with 1:200,000 adrenaline solution. The midline incision was deepened to expose the occipital bone. A pair of self-retaining retractors was applied. Sub-occipital craniectomy was achieved along the inferior edges of the transverse sinuses and posterior edges of the sigmoid sinuses. T-shaped durotomy was made, and the tumor was visible through the median foramen of Magendie. Neuro-patties were threaded into the floor of the fourth ventricle as an intraoperative landmark. The tumor was coagulated with bipolar diathermy. The tumor-brain interface was delineated, and the tumor was dissected and mobilized. There was an intraoperative tumor rupture with an estimated blood loss of 1 L. The hemostasis was secured, and he was transfused with three units of whole blood (500 mL/unit). The tumor bed and fourth ventricle were copiously irrigated with warm normal saline until the return was clear. Intraoperative findings confirmed a highly vascular lesion consistent with a hemangioblastoma [Figure 2]. Postoperative histopathology [Figure 3] revealed a proliferation of stromal and endothelial cells with characteristic vacuolated cytoplasm, confirming the diagnosis. Immunohistochemistry shows tumor cells that are positive for CD34 but negative for AE1/AE3. Preoperative brain Magnetic resonance imaging(A and B) - (A) T1 post-contrast sagittal and (B) axial images; Postoperative cranial computed tomography scan- (C) sagittal and (D) axial images. (A)- Highly vascularized cerebellar tumor (arrow points at the tumor) that is predominantly solid; (B)- Tumor specimen. (A) Hematoxylin and Eosin stain of the tumor showing vascularized tumor with vacuolated stroma cells (×100 magnification). (B) Hematoxylin and Eosin stain of the tumor showing a vascularized tumor with stromal cells that have vacuolated cytoplasm (×400 magnification). (C) CD34 positive immunostain of the vascular tumor (×100 magnification). (D) AE1/AE negative immunostain of the stromal tumor cells (×100 magnification). The patient had an uneventful postoperative course, with significant improvement in gait stability and no neurological deficits. He has resumed his premorbid activities; he drives and carries out daily activities without assistance. The 2-year postoperation follow-up review showed a healthy patient with no recurrence of the symptoms, but he declined a repeat neuroimaging. DISCUSSION Hemangioblastomas are benign, slowly growing, highly vascular neoplasms containing neoplastic stromal cells that usually involve the cerebellum, brainstem, or spinal cord. The incidence of hemangioblastoma is 0.141/100,000 person-year.[14] The cerebellar hemangioblastoma accounts for about 1–2% of central nervous system (CNS) tumors and about 7–12% of primary posterior fossa tumors.[7] The tumor occurs slightly more in males with a male-to-female ratio of 1–1.25:1.[12] Hemangioblastomas are often cystic, while very few may be solid. The solid type hemangioblastomas are rare, highly vascularized benign tumors classified as the World Health Organization grade I. They predominantly occur in the posterior fossa, particularly the cerebellum, and may present sporadically or in association with VHL disease, which is generally associated with loss or inactivation of the VHL gene.[6] The type associated with VHL disease are often familial and usually involves other organs such as the retina (retinal hemangioblastoma/angioma), head/neck (paragangioma), kidney (clear cell renal cell carcinoma [RCC] and cysts), adrenal (pheochromocytoma), pancreas (neuroendocrine islet cell tumor and cysts), inner ear (endolymphatic sac tumor), epididymis (papillary cystadenoma), and broad ligament (cystadenoma).[7] In the index case, the absence of systemic findings or family history ruled out VHL syndrome, which is commonly associated with multiple lesions and systemic manifestations. The patient had 2 years of clinical examination follow-up visits with no manifestation of VHL-associated diseases, supporting the diagnosis of a sporadic variant of a solid cerebellar hemangioblastoma. The mean age of presentation of the sporadic variant is approximately 47 years, while the mean age for the type associated with VHL disease is approximately 29 years.[7] The age of the index patient (60 years) falls within the reported range (mid-40 s to early 70 s) for sporadic cerebellar hemangioblastomas, though sporadic solid variants in older patients remain uncommon. The solid hemangioblastomas can mimic metastatic brain lesions such as metastatic clear cell RCC, or other vascular tumors, including angiomatous meningiomas. Accurate differentiation relies on imaging and histopathology with immunophenotyping. Magnetic resonance imaging (MRI) of the hemangioblastomas typically reveals a well-circumscribed, hypervascular lesion. The solid component shows intense gadolinium enhancement due to its rich vascularity.[5] A CT scan of the tumor demonstrates an isodense or slightly hyperdense lesion with homogenous enhancement after contrast administration.[4] A brain MRI was done for the index patient, which shows a hypervascular, well-circumscribed, intensely enhancing solid tumor with a small cystic component suggestive of hemangioblastoma. Grossly, hemangioblastomas appear as either a solid or cystic mass with a mural nodule. They are usually well circumscribed, highly vascular, and with pseudocapsulation. Their cut surfaces are usually red to yellow/orange - attributed to their lipid content. Sporadic cerebellar hemangioblastomas mostly present as cystic tumors with a small mural nodule; solid tumors represent a smaller subset. Histologically, the tumor consists of numerous thin-walled capillaries that are interspersed with stromal cells that have foamy cytoplasm. These tumors lack mitotic activity and necrosis, reflecting their benign nature. The histologic variants include the reticular variant with more capillaries than stroma cells, and the cellular variant that has more stromal cells than capillaries. The solid-type hemangioblastomas, unlike the cystic variants, have dense cellularity without significant cystic components. With the application of immunohistochemistry, the stromal cells are often stained positive for Inhibin alpha and N-CAM 1, while the vascular cells are positive for the endothelial cell markers such as CD31 and CD34.[2,8,9] The tumor cells often stain negatively for cytokeratin markers such as AE1/AE3.[11] They also stain negative to CAM5.2, RCC marker, PAX 8, CD 10, Epithelial membrane antigen, Neuron-specific enolase, and Glial fibrillary acidic protein.[2, 8,9,11,12] The definitive diagnosis of the index case was made with the classical histologic findings of a highly vascularized tumor composed of neoplastic stromal cells that have clear foamy cytoplasm with lipid-containing vacuoles. The vascular component stained positively for the CD34 immunostain. The stromal tumor cells stained negative for AE1/AE3, which excludes the possibility of a metastatic clear cell RCC, a close differential to CNS hemangioblastoma. Clinically, patients with cerebellar hemangioblastoma often present with symptoms of cerebellar dysfunction such as ataxia, dysmetria, dizziness, and coordination issues. They may also have signs of increased intracranial pressure (e.g., headaches and nausea) due to the mass effect of hydrocephalus.[5] These symptoms, including gait instability, dizziness, and headaches, were present in the index case. Surgical resection is the treatment of choice. Complete removal is often curative due to the tumor’s benign nature and clear demarcation from surrounding tissue. Postoperative outcomes are generally favorable, with a low recurrence rate if resection is complete.[13] Solid hemangioblastomas tend to have a higher risk of intraoperative hemorrhage, an obscure tumor-brain interface, and a poorer prognosis compared to the more common cystic type.[3,13] Preoperative embolization of arteries that supply solid hemangioblastoma can be done to reduce intraoperative bleeding and improve prognosis.[3] In rare cases, dissemination through cerebrospinal fluid has been reported, emphasizing the need for long-term follow-up in some patients.[1] The clinical outcome of the index patient, following complete surgical removal of the tumor, has been excellent. There has been a significant improvement in his symptoms, and no tumor recurrence. Limitations This case report has some limitations inherent to our resource-limited setting. First, chest and abdominopelvic CT scans, as recommended for comprehensive metastatic workup, were not performed; instead, plain chest X-ray and abdominopelvic ultrasound were used due to cost constraints and availability. While ultrasound ruled out gross abdominal malignancies (e.g., RCC), it has lower sensitivity than CT for small retroperitoneal or chest lesions, potentially missing occult metastases. Second, PSA testing was omitted, justified by normal DRE, absence of prostate symptoms/history, and rarity of isolated highly vascular posterior fossa prostate metastases; however, this does not fully exclude the possibility. Third, genetic testing for VHL gene mutations was unavailable, precluding molecular confirmation of sporadic status; clinical/radiologic exclusion remains presumptive. These gaps highlight challenges in low-resource diagnostics but do not alter the histopathologically confirmed diagnosis. CONCLUSION While hemangioblastomas are recognized in posterior fossa masses, the solid sporadic variant in elderly patients is frequently overlooked due to its rarity and the typical cystic presentation of hemangioblastomas. Our report raises awareness of this diagnostic challenge and underscores the need for a high clinical suspicion. This case also highlights the importance of integrating clinical presentation, imaging findings, and histopathological examination for accurate diagnosis and management of cerebellar solid-type hemangioblastomas. A gross total excision is usually curative with a good prognosis.